Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076171897> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2076171897 endingPage "12" @default.
- W2076171897 startingPage "3" @default.
- W2076171897 abstract "Evolution of the roles proposed for antiandrogenic agents in prostatic disease has been rapid. Since the early suggestions by Labrie and his colleagues that the nonsteroidal antiandrogen flutamide could be used in combination with medical or surgical castration to provide superior care for patients with metastatic prostate cancer, and subsequent substantiation of that theory in a number of clinical trials, we have observed an increasing tendency to test the use of antiandrogens (alone or in combination with other interventions) earlier in the disease process. At least in part, this tendency is a consequence of our increased ability to detect prostate cancer earlier in the disease process. At the present time, flutamide is the only nonsteroidal antiandrogen available for the treatment of prostate cancer in general clinical practice in the United States. However, two other nonsteroidal antiandrogens currently await decisions on their efficacy and safety by the Food and Drug Administration: nilutamide and bicalutamide. Will either of these agents offer clinical benefits beyond those offered by flutamide? Will the safety, activity, and dosing profiles of the nonsteroidal antiandrogens allow us to use them to treat even earlier stages of prostate cancer and perhaps even prostatic intraepithelial dysplasia in patients at high risk of prostate cancer? What are the potential future roles for bicalutamide and other nonsteroidal antiandrogens in the management of prostatic disorders? This article will attempt to lay out the key questions that await definitive answers as we expand our understanding of the possible future roles for antiandrogens in the management of prostate cancer and related conditions." @default.
- W2076171897 created "2016-06-24" @default.
- W2076171897 creator A5001069772 @default.
- W2076171897 date "1996-01-01" @default.
- W2076171897 modified "2023-10-14" @default.
- W2076171897 title "Hormone therapy for prostate cancer: a topical perspective" @default.
- W2076171897 cites W116367892 @default.
- W2076171897 cites W1978267162 @default.
- W2076171897 cites W1982082358 @default.
- W2076171897 cites W1994047807 @default.
- W2076171897 cites W1997879387 @default.
- W2076171897 cites W2010992034 @default.
- W2076171897 cites W2013354835 @default.
- W2076171897 cites W2014145760 @default.
- W2076171897 cites W2021260370 @default.
- W2076171897 cites W2022690114 @default.
- W2076171897 cites W2055825014 @default.
- W2076171897 cites W2069228387 @default.
- W2076171897 cites W2069254058 @default.
- W2076171897 cites W2069972733 @default.
- W2076171897 cites W2092991204 @default.
- W2076171897 cites W2165631552 @default.
- W2076171897 cites W2325739201 @default.
- W2076171897 cites W2399270088 @default.
- W2076171897 cites W2406031689 @default.
- W2076171897 cites W2409991602 @default.
- W2076171897 cites W3021430124 @default.
- W2076171897 cites W4253882649 @default.
- W2076171897 cites W4293658047 @default.
- W2076171897 cites W8603049 @default.
- W2076171897 doi "https://doi.org/10.1016/s0090-4295(96)80002-1" @default.
- W2076171897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8560675" @default.
- W2076171897 hasPublicationYear "1996" @default.
- W2076171897 type Work @default.
- W2076171897 sameAs 2076171897 @default.
- W2076171897 citedByCount "12" @default.
- W2076171897 countsByYear W20761718972022 @default.
- W2076171897 crossrefType "journal-article" @default.
- W2076171897 hasAuthorship W2076171897A5001069772 @default.
- W2076171897 hasConcept C121608353 @default.
- W2076171897 hasConcept C126322002 @default.
- W2076171897 hasConcept C143998085 @default.
- W2076171897 hasConcept C2776235491 @default.
- W2076171897 hasConcept C2778313021 @default.
- W2076171897 hasConcept C2779322244 @default.
- W2076171897 hasConcept C2780192828 @default.
- W2076171897 hasConcept C2780962315 @default.
- W2076171897 hasConcept C2910016293 @default.
- W2076171897 hasConcept C29456083 @default.
- W2076171897 hasConcept C61367390 @default.
- W2076171897 hasConcept C71924100 @default.
- W2076171897 hasConceptScore W2076171897C121608353 @default.
- W2076171897 hasConceptScore W2076171897C126322002 @default.
- W2076171897 hasConceptScore W2076171897C143998085 @default.
- W2076171897 hasConceptScore W2076171897C2776235491 @default.
- W2076171897 hasConceptScore W2076171897C2778313021 @default.
- W2076171897 hasConceptScore W2076171897C2779322244 @default.
- W2076171897 hasConceptScore W2076171897C2780192828 @default.
- W2076171897 hasConceptScore W2076171897C2780962315 @default.
- W2076171897 hasConceptScore W2076171897C2910016293 @default.
- W2076171897 hasConceptScore W2076171897C29456083 @default.
- W2076171897 hasConceptScore W2076171897C61367390 @default.
- W2076171897 hasConceptScore W2076171897C71924100 @default.
- W2076171897 hasIssue "1" @default.
- W2076171897 hasLocation W20761718971 @default.
- W2076171897 hasLocation W20761718972 @default.
- W2076171897 hasOpenAccess W2076171897 @default.
- W2076171897 hasPrimaryLocation W20761718971 @default.
- W2076171897 hasRelatedWork W1975376586 @default.
- W2076171897 hasRelatedWork W1994967822 @default.
- W2076171897 hasRelatedWork W2039360526 @default.
- W2076171897 hasRelatedWork W2065112594 @default.
- W2076171897 hasRelatedWork W2067438553 @default.
- W2076171897 hasRelatedWork W2094670275 @default.
- W2076171897 hasRelatedWork W2429123467 @default.
- W2076171897 hasRelatedWork W3003821987 @default.
- W2076171897 hasRelatedWork W4211117799 @default.
- W2076171897 hasRelatedWork W4255890258 @default.
- W2076171897 hasVolume "47" @default.
- W2076171897 isParatext "false" @default.
- W2076171897 isRetracted "false" @default.
- W2076171897 magId "2076171897" @default.
- W2076171897 workType "article" @default.